K-numberK241822
Device nameReWalk® 7 Personal Exoskeleton (50-20-0005)
ApplicantRewalk Robotics Ltd. Dba Lifeward
Product codePHL
Device classClass II
Decision dateMar 12, 2025
DecisionSubstantially Equivalent
Regulation890.3480
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ReWalk 7 Personal Exoskeleton is a wearable, battery-powered device that enables individuals with spinal cord injury (T7–L5 in home/community settings, T4–T6 in rehabilitation facilities) to stand and walk using motorized knee and hip joints controlled via a wireless wrist control unit or crutch-mounted control unit. It is intended for indoor and outdoor use on level surfaces, mild slopes, and stairs.

Technological characteristics

The ReWalk 7 replaces the predicate ReWalk P6.0's proprietary remote control with an off-the-shelf wireless wrist control unit (WCU) and adds an optional crutch-mounted control unit (CCU). It implements a new smart rechargeable lithium-ion battery following a recall, slightly increasing overall weight with negligible center-of-mass change. It also introduces pseudo-stand and pseudo-descent modes for stairs and adds a cloud-connected therapist handheld device (THD) for configuration instead of laptop-only maintenance.

Test standards cited

IEC 60601-1-1, IEC 60601-1-2, IEC TR 60601-4-2, IEC 60601-1-11, IEC 62133-2, IEC 60601-1-6, IEC 62366-1, IEC 62304, ISO 10993-1, ISO 10993-5, ISO 10993-10, AAMI TIR69:2017, ISO 14971, AAMI TIR57:2016, IEC 80601-2-78, ASTM D4332-22, and ASTM D4169-22.

Substantial equivalence argument

The ReWalk 7 maintains identical indications for use, contraindications, and basic operating principles as the predicate ReWalk P6.0. The enhancements (battery replacement, control unit upgrades, new operational modes, and connectivity features) focus on safety, user interface improvements, and device connectivity rather than altering the fundamental mechanism or intended use. Substantial equivalence testing confirmed that ReWalk 7 performs safely and effectively with the same performance characteristics as its predicate, demonstrating no new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →